LifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major Winner - Buy
LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...
LifeVantage announces results of third-party cell study of health weight stack
LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer ...
Craig-Hallum bullish on LifeVantage, initiates with a Buy
As previously reported, Craig-Hallum initiated coverage of LifeVantage (LFVN) with a Buy rating and $35 price target Interest in weight loss ...
LifeVantage Study Confirms Breakthrough Synergistic Effects of Healthy Weight Stack*
LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of ...
Top US Growth Stocks With Strong Insider Ownership
As the U.S. stock market navigates a mixed landscape with the S&P 500 inching higher and tech stocks experiencing volatility, investors are keenly observing growth companies with substantial insider ...
manilatimes7d
LifeVantage Announces Preliminary Second Quarter Revenue Results and Raises Fiscal 2025 Revenue Guidance
LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal ...
Taiwan News7d
LifeVantage Announces Preliminary Second Quarter Revenue Results and Raises Fiscal 2025 Revenue Guidance
reflecting strong sales of the MindBody GLP-1 System™ we launched in October in the United States along with outstanding execution by our team to quickly ramp supply chain and fulfillment capacity to ...